NOLA.com19h
New prostate cancer drug can extend life expectancy by 8 months, Baton Rouge doctor says
"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...
WSYR Syracuse on MSN11h
CNY man is first patient in US to receive new prostate cancer treatment
On March 28, the Food and Drug Administration approved Pluvicto, a new radiation agent able to treat patients with prostate cancer. Just six days later, James ...
Bernstein Reaffirms Their Buy Rating on Novartis AG (NOVN)
In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on Novartis AG (NOVN – Research Report), with a price ...
Deutsche Bank Remains a Buy on Novartis AG (NOVN)
Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novartis AG (NOVN – Research Report) today and set a price target of ...